A detailed history of Advisory Services Network, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Advisory Services Network, LLC holds 71 shares of MGNX stock, worth $109. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Holding current value
$109
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 18, 2025

BUY
$1.29 - $2.1 $91 - $149
71 New
71 $0
Q4 2020

Feb 09, 2021

SELL
$19.41 - $26.0 $407 - $546
-21 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$24.69 - $31.6 $518 - $663
21 New
21 $1,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $94.6M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.